Elysa R Davidson, LPN in Longmont, CO - Licensed Vocational Nurse

Elysa R Davidson, LPN is a Licensed Vocational Nurse based in Longmont, Colorado. Elysa R Davidson is licensed to practice in Colorado (license number 44461) and her current practice location is 2345 Bent Way, Longmont, Colorado. She can be reached at her office (for appointments etc.) via phone at (303) 678-3200.

NPI number for Elysa R Davidson is 1356539654 and her current mailing address is 4900 Boardwalk Dr, N204, Fort Collins, Colorado. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1356539654.

Contact Information

	Elysa R Davidson, LPN
	2345 Bent Way, Longmont, CO 80503-7614
	(303) 678-3200
	Not Available

Provider's Profile

Full Name	Elysa R Davidson
Gender	Female
Speciality	Licensed Vocational Nurse
Location	2345 Bent Way, Longmont, Colorado
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1356539654
Provider Enumeration Date: 10/11/2007
Last Update Date: 10/11/2007

Medical Identifiers

Medical identifiers for Elysa R Davidson such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1356539654	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
164X00000X	Licensed Vocational Nurse	44461 (Colorado)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Elysa R Davidson is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Elysa R Davidson, LPN 4900 Boardwalk Dr, N204, Fort Collins, CO 80525-6226 Ph: (970) 631-9486	Elysa R Davidson, LPN 2345 Bent Way, Longmont, CO 80503-7614 Ph: (303) 678-3200

News Archive

Salix Pharmaceuticals receives FDA response for Balsalazide tablet

Salix Pharmaceuticals, Ltd. has announced that the Company has received a complete response letter from the U.S. Food and Drug Administration (FDA) for its New Drug Application (NDA) for balsalazide tablet studied as a treatment of mild-to-moderate active ulcerative colitis in patients 18 years and older.

RIFM publishes special issue on safety assessment of unsaturated alcohols

The Research Institute for Fragrance Materials, Inc. (RIFM) has now published on the RIFM web site, in the Publications section, a special issue of Food and Chemical Toxicology, Volume 48, Supplement 3, on the RIFM Human Health Group Summary, A Safety Assessment of Non-cyclic Alcohols with Unsaturated Branched Chain when used as Fragrance Ingredients.

Use of oral fluconazole during pregnancy associated with increased risk of spontaneous abortion

In an analysis of approximately 1.4 million pregnancies in Denmark, use of the oral antifungal medication fluconazole during pregnancy was associated with an increased risk of spontaneous abortion compared with risk among unexposed women and women who used a topical antifungal during pregnancy, according to a study in the January 5 issue of JAMA.

Progress in developing new pig breeds with a desirable combination of both leanness and flavor

Perhaps you can't make a silk purse out of a sow's ear, but scientists are reporting progress in pulling off the same trick with the notoriously bland flavor of pork. They are reporting new insights into the biochemical differences in the meat of an Italian swine renowned for its good flavor since the ancient Roman Empire and the modern "Large White" or Yorkshire hog, whose roots date back barely 125 years. Their study appears in ACS' Journal of Proteome Research.

Elysa R Davidson, LPN - Licensed Vocational Nurse in Longmont, CO